Abstract
Rasmussen’s syndrome (chronic encephalitis with epilepsy) is a rare neurological disorder characterised by progressive dysfunction of one cerebral hemisphere. Clinical and radiological features of the syndrome include intractable epilepsy, cognitive and motor decline, progressive unilateral cortical atrophy and the occurrence of epilepsia partialis continua (EPC) in many cases. Histopathological findings include the presence of perivascular cuffing, microglial nodules, gliosis and spongiosis. The aetiology of Rasmussen’s encephalitis is unknown but viral, autoimmune and genetic mechanisms have been postulated. Proposed therapies have included anticonvulsants, corticosteroids, antiviral agents, interferona, immunogobulin and plasmapheresis. The mainstay of therapy is hemispherectomy. To date, no medical therapies have permanently halted neurological deterioration. A better understanding of pathogenesis is required to develop safe and effective medical therapies.
Similar content being viewed by others
References
Rasmussen T, Olszewski J, Lloyd-Smith D. Focal seizures due to chronic localized encephalitis. Neurology 1958; 8: 435–45
Whitney KD, Andrews PI, McNamara JO. Immunoglobulin G and complement immunoreactivity in the cerebral cortex of patients with Rasmussen’s encephalitis. Neurology 1999; 53(4): 699–708
Levite M, Hermelin A. Autoimmunity to the glutamate receptor in mice: a model for Rasmussen’s encephalitis? J Autoimmun 1999; Aug 13(1): 73–82
Levite M, Fleidervish IA, Schwarz A, et al. Autoantibodies to the glutamate receptor kill neurons via activation of the receptor ion channel. J Autoimmun 1999; Aug 13(1): 61–72
Andermann E, Oguni H, Guttmann RD, et al. Genetic aspects of chronic encephalitis. In: Andermann F, editor. Chronic encephalitis and epilepsy, Rasmussen’s syndrome. Stoneham (MA): Butterworth-Heinmann, 1991: 167–75
Li Y, Uccelli A, Laxer KD, et al. Local-clonal expansion of infiltrating T lymphocytes in chronic encephalitis of Rasmussen. J Immunol 1997; 158(3): 1428–37
Lyon G, Griscelli C, Fernandez AE, et al. Chronic progressive encephalitis in children with X-linked hypogammaglobulinemia. Neuropadiatrie 1980; 11: 57–71
Andrews JM, Thompson JA, Pysher TJ, et al. Chronic encephalitis, epilepsy, and cerebrovascular immune complex deposits. Ann Neurol 1990; 28: 88–90
Hart YM, Andermann F, Robitaille Y, et al. Double pathology in Rasmussen’s syndrome: a window on the etiology? Neurology 1998; 50: 731–5
Grenier Y, Antel JP, Osterland CK. Immunologic studies in chronic encephalitis of Rasmussen. In: Andermann F, editor. Chronic encephalitis and epilepsy, Rasmussen’s syndrome. Stoneham (MA): Butterworth-Heinmann, 1991: 125–34
Asher DM, Gajdusek DC. Virologic studies in chronic encephalitis. In: Andermann F, editor. Chronic encephalitis and epilepsy, Rasmussen’s syndrome. Stoneham (MA): Butterworth-Heinmann, 1991: 147–58
So NK, Andermann F. Rasmussen’s syndrome. In: Jr Engel J, Pedley TA, editors. Epilepsy: a comprehensive textbook. Philadelphia (PA): Lippincott-Raven Publishers, 1997: 2379–88
Fukuda T, Oguni H, Yanagaki S, et al. Chronic localized encephalitis (Rasmussen’s syndrome) preceded by ipsilateral uveitis: a case report. Epilepsia 1994; 35(6): 1328–31
Harvey AS, Andermann F, Hopkins IJ. Chronic encephalitis (Rasmussen’s syndrome) and ipsilateral uveitis. Ann Neurol 1992; 32: 826–9
McLachlan RS, Levin S, Blume WT. Treatment of Rasmussen’s syndrome with ganciclovir. Neurology 1996; 47: 925–8
Jay V, Becker LE, Otsubo H, et al. Chronic encephalitis and epilepsy (Rasmussen’s encephalitis): detection of cytomegalovirus and herpes simplex virus 1 by the polymerase chain reaction and in situ hybridization. Neurology 1995; 45: 108–17
Friedman H, Ch’ien L, Parham D. Virus in the brain of a child with hemiplegia, hemiconvulsions, and epilepsy [letter]. Lancet 1977; II: 666
Laxer KD, Gilden DH, Burkhardt C, et al. Detection of herpes simplex virus nucleic acid in human cortex from patients with complex partial seizures [abstract]. Epilepsia 1986; 27: 594
Walter GF, Renella RR. Epstein-Barr viras in brain and Ras-mussen’s encephalitis [letter]. Lancet 1989; I: 279–80
Rogers SW, Andrews PI, Gahring LC, et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen’s encephalitis. Science 1994; 265: 648–51
Poza JJ, Saenz A, Nartines-Gil A, et al. Autosomal dominant lateral temporal epilespsy: clinical and gene study of a large Basque pedigree linked to chromosome 10q. Ann Neurol 1999; 45(2): 182–8
Scheffer IE, Phillips HA, O’Brien CE, et al. Familial partial epilepsy with variable foci: a new partial epilepsy syndrome with suggestion of linkage to chromosome 2. Ann Neurol 1998; 44(6): 890–9
Winawer MR, Ottman R, Hauser WA, et al. Autosomal dominant partial epilepsy with auditory features: defining the phenotype. Neurology 2000; 54(11): 2173–6
Rasmussen T, Andermann F. Rasmussen’s syndrome: symptomatology of the syndrome of chronic encephalitis and seizures: 35-year experience with 51 cases. In: Luders H, editor. Epilepsy Surgery. New York (NY): Raven Press, 1991: 173–82
Bancaud J. Kozhevnikov’s syndrome (epilepsia partialis continua) in children. In: Roger J, Dravet C, Dureau M,et al., editors. Epileptic syndromes in infancy, childhood and adolescence. London: John Libbey, 1985: 286–98
Dulac O, Dravet C, Plouin P, et al. Aspects nosologiques des epilepsies partielles continues chez l’enfant. Arch Fr Pediatr 1983; 40: 689–95
Gray F, Serdaru M, Baron H, et al. Chronic localized encephalitis (Rasmussen’s) in an adult with epilepsia partialis continua. J Neurol Neurosurg Psychiatry 1987; 50: 747–51
Gupta PC, Roy S, Tandon PN. Progressive epilepsy due to chronic persistent encephalitis: report of 4 cases. J Neurol Sci 1974; 22: 105–20
Piatt Jr JH, Hwang PA, Armstrong DC, et al. Chronic focal encephalitis (Rasmussen syndrome): six cases. Epilepsia 1988; 29(3): 268–79
Chinchilla D, Dulac O, Robain O, et al. Reappraisal of Rasmussen’ s syndrome with special emphasis on treatment with high doses of steroids. J Neurol Neurosur Psychiatry 1994; 57: 1325–33
Morrell F, Whisler WW, Smith MC. Multiple subpial transection in Rasmussen’s encephalitis. In: Andermann F, editor. Chronic encephalitis and epilepsy, Rasmussen’s syndrome. Stoneham (MA): Butterworth-Heinmann, 1991: 219–33
Dulac O. Why is Rasmussen’s encephalitis unilateral? In: Wolf P, editor. Epileptic Seizures and Syndromes. London: John Libbey, 1994: 391–4
Oguni H, Andermann F, Rasmussen TB. The natural history of the syndrome of chronic encephalitis and epilepsy: a study of the MNI series of forty-eight cases. In: Andermann F, editor. Chronic encephalitis and epilepsy, Rasmussen’s syndrome. Stoneham (MA), Butterworth-Heinmann, 1991: 7–35
Vining EPG, Freeman JM, Brandt J, et al. Progressive unilateral encephalopathy of childhood (Rasmussen’s syndrome): a reappraisal. Epilepsia 1993; 34(4); 639–50
Taylor LB. Neuropsychologic assessment of patients with chronic encephalitis. In: Andermann F, editor. Chronic encephalitis and epilepsy, Rasmussen’s syndrome. Stoneham (MA): Butterworth-Heinmann, 1991: 111–21
Hart YM, Cortez M, Andermann F, et al. Medical treatment of Rasmussen’s syndrome (chronic encephalitis and epilepsy): effect of high dose steroids or immunoglobulins in 19 patients. Neurology 1994; 44; 1030–6
Laxer KD. Temporal lobe epilepsy with inflammatory pathologic changes. In: Andermann F, editor. Chronic encephalitis and epilepsy, Rasmussen’s syndrome. Stoneham (MA): Butterworth-Heinmann, 1991: 135–40
So NK, Gloor P. Electroencephalographic and electrocortico-graphic findings in chronic encephalitis of the Rasmussen type. In: Andermann F, editor. Chronic encephalitis and epilepsy, Rasmussen’s syndrome. Stoneham (MA): Butterworth-Heinmann, 1991: 37–45
Dulac O, Robain O, Chiron C, et al. High-dose steroid treatment of epilepsia partialis continua due to chronic focal encephalitis. In: Andermann F, editor. Chronic encephalitis and epilepsy, Rasmussen’s syndrome. Stoneham (MA): Butterworth-Heinmann, 1991: 193–9
Capovilla G, Paladin F, Dalla Bernardina B. Rasmussen’s syndrome: longitudinal EEG study from the first seizure to epilepsia partialis continua. Epilepsia 1997; 38(4): 483–8
Tampieri D, Melanson D, Ethier R. Imaging of chronic encephalitis. In: Andermann F, editor. Chronic encephalitis and epilepsy, Rasmussen’s syndrome. Stoneham (MA): Butterworth-Heinmann, 1991: 47–60
Hwang PA, Gilday DL, Spire JP, et al. Chronic focal encephalitis of Rasmussen: functional neuroimaging studies with positron emission tomography and single-photon emission computed tomography scanning. In: Andermann F, editor. Chronic encephalitis and epilepsy, Rasmussen’s syndrome. Stoneham (MA): Butterworth-Heinmann, 1991: 61–72
Hwang PA, Gilday DL, Ash JM, et al. Perturbations in cerebral blood flow detected by SPECT scanning with 99Tc-Hm-PAO correlate with EEG abnormalities in children with epilepsy. J Cerebral Blood Flow Metab 1987; 7(1 Suppl. ): 573S
Maria BL, Ringdahl DM, Mickle JP, et al. Intraventricular alpha interferon therapy for Rasmussen’s syndrome. Can J Neurol Sci 1993; 20: 333–6
Caplan R, Curtiss S, Chugani HT, et al. Pediatric Rasmussen encephalitis: social communication, language, PET, and pathology before and after hemispherectomy. Brain Cogn 1996; 32: 45–66
Chugani HT, Shewmon DA, Peacock WJ, et al. Surgical treatment of intractable neonatal-onset seizures: the role of positron emission tomography. Neurology 1988; 38(8): 1178–88
Duprez TPJ, Grandin C, Gadisseux JF, et al. MR-monitored remitting-relapsing pattern of cortical involvement in Rasmussen syndrome: comparative evaluation of serial MR and PET/SPECT features. JComput Assist Tomogr 1997; 21(6): 900–4
Cendes F, Andermann F, Silver K, et al. Imaging of axonal damage in vivo in Rasmussen’s syndrome. Brain 1995; 118: 753–8
Geller E, Faerber EN, Legido A, et al. Rasmussen encephalitis: complementary role of multitechnique neuroimaging. AJNR Am J Neuroradiol 1998 Mar; 19(3): 445–9
Robitaille Y. Neuropathologic aspects of chronic encephalitis. In: Andermann F, editor. Chronic encephalitis and epilepsy, Rasmussen’s syndrome. Stoneham (MA): Butterworth-Heinmann, 1991: 79–110
Hart Y, Fish D, Robitaille Y, et al. Progress in the semiology of Rasmussen’s encephalitis: adolescent or adult onset and double pathology. In: Wolf P, editor. Epileptic seizures and syndromes. London: John Libbey, 1994: 395–8
Yacubian EMT, Rosemberg S, Marie SKN, et al. Double pathology in Rasmussen’s encephalitis etiologic considerations. Epilepsia 1996; 37(5): 495–500
Aicardi J, Goutieres F, Arsenio-Nunes HL, et al. Acute measles encephalitis in children with immunosuppression. Pediatrics 1977; 55: 232–9
Lyon G, Ponsot G, Lebon P. Acute measles encephalitis of the delayed type. Ann Neurol 1977; 2: 322–7
Wilson DC, McGibben D, Hicks EM, et al. Progressive neuronal degeneration of childhood (Alpers syndrome) with hepatic cirrhosis. Eur J Pediatr 1993; 152(3): 260–2
Worle H, Kohler B, Schlote W, et al. Progressive cerebral degeneration of childhood with liver disease (Alpers Huttenlocher disease) with cytochrome oxidase deficiency presenting with epilepsia partialis continua as the first clinical manifestation. Clin Neuropathol 1988; 17(2): 63–8
Tran TX, Palmer SC, Ni OK, et al. Epilepsia partialis continua as a presenting manifestation of diabetic ketoacidosis. Ann Neurol 1999; 46(3): 546
Dabbagh O, Gascon G, Crowell J, et al. Intraventricular inter-feron-alpha stops seizures in Rasmussen’s encephalitis: a case report. Epilepsia 1997; Sep 38(9): 1045–9
Wise MS, Rutledge SL, Kuzniecky RI. Rasmussen syndrome and long-term response to gamma globulin. Pediatr Neurol 1996; 14: 149–52
DeToledo JC, Smith DB. Partially successful treatment of Rasmussen’s encephalitis with zidovudine: symptomatic improvement followed by involvement of the contralateral hemisphere. Epilepsia 1994; 35(2): 352–5
Larner AJ, Anderson M. Rasmussen’s syndrome: pathogenetic theories and therapeutic strategies. J Neurol 1995; 242: 355–8
III Snead OC, Benton JW, Myers GJ. ACTH and prednisone in childhood seizure disorders. Neurology 1983; 33: 966–70
Conford E, Oldendorf W. Epilepsy and blood brain barrier. In: Delgado-Escueta A, Ward A, Woodbury D, et al. editors. Advances in neurology: basic mechanisms of epilepsies. New York (NY): Raven Press, 1986: 787–812
Krauss GL, Campbell ML, Roche KW, et al. Chronic steroid-responsive encephalitis without autoantibodies to glutamate receptor GluR 3. Neurology 1996; 46: 247–9
Weiss K. Safety profile of Interferon-alpha therapy. Semin Oncol 1998; 25(1 Suppl. 1): 9–13
Valentine AD, Meyers CA, Kling MA, et al. Mood and cognitive side effects of interferon-alpha therapy. Semin Oncol 1998; 25(1 Suppl. 1): 39–47
Andrews PI, Dichter MA, Berkovic SF, et al. Plasmapheresis in Rasmussen’s encephalitis. Neurology 1996; 46: 242–6
Villemure JG, Rasmussen T. Functional hemispherectomy in children. Neuropediatrics 1993; 24: 53–5
Adams, CBT. Hemispherectomy — a modification. J Neurol Neurosurg Psychiatry 1983; 46: 617–9
Delalande O, Pinard JM, Basdevant C, et al. Hemispherotomy: A new procedure for central disconnection. Epilepsia 1992; 33 Suppl. 3: 99–100
Villemure JG, Andermann F, Rasmussen TB. Hemispherectomy for the treatment of epilepsy due to chronic encephalitis. In: Andermann F, editor. Chronic encephalitis and epilepsy, Rasmussen’s syndrome. Stoneham (MA): Butterworth-Heinmann, 1991: 235–41
Honavar M, Janota I, Polkey CE. Rasmussen’s encephalitis in surgery for epilepsy. Dev Med Child Neurol 1992; 34: 3–14
Lilly D. Functional hemispherectomy: Radical treatment for Rasmussen’s encephalitis. Am J Neuroscience Nurses 2000. In press
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tran, T.X., Day, J.A., Eskin, T.A. et al. Rasmussen’s Syndrome. Mol Diag Ther 14, 343–354 (2000). https://doi.org/10.2165/00023210-200014050-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00023210-200014050-00002